BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28074676)

  • 1. Potential route of Th17/T
    Karri SK; Sheela A
    Br J Biomed Sci; 2017 Jan; 74(1):8-15. PubMed ID: 28074676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
    Astry B; Venkatesha SH; Moudgil KD
    Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.
    Kim EY; Moudgil KD
    Cytokine; 2017 Oct; 98():87-96. PubMed ID: 28438552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in autoimmunity: role in induction, regulation, and treatment.
    Moudgil KD; Choubey D
    J Interferon Cytokine Res; 2011 Oct; 31(10):695-703. PubMed ID: 21942420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Th17 and Treg cells in septic arthritis and the impact of the Th17/Treg -derived cytokines in the pathogenesis of S. aureus induced septic arthritis in mice.
    Dey I; Bishayi B
    Microb Pathog; 2017 Dec; 113():248-264. PubMed ID: 29074430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
    Schinnerling K; Aguillón JC; Catalán D; Soto L
    Clin Exp Immunol; 2017 Jul; 189(1):12-20. PubMed ID: 28369786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unregulated IL-23/IL-17 immune response in autoimmune diseases.
    Costa VS; Mattana TC; da Silva ME
    Diabetes Res Clin Pract; 2010 Jun; 88(3):222-6. PubMed ID: 20392505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
    Stadhouders R; Lubberts E; Hendriks RW
    J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
    Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
    Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis.
    Kelepouri D; Mavropoulos A; Bogdanos DP; Sakkas LI
    J Immunol Res; 2018; 2018():9324357. PubMed ID: 29693024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay among cytokines and T cell subsets in the progression and control of immune-mediated diseases.
    Moudgil KD
    Cytokine; 2015 Jul; 74(1):1-4. PubMed ID: 26026376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Helper T cell paradigm: Th17 and regulatory T cells involved in autoimmune inflammatory disorders, pathogen defense and allergic diseases].
    Noma T
    Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(5):262-71. PubMed ID: 21048387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.
    Yan L; Hu F; Yan X; Wei Y; Ma W; Wang Y; Lu S; Wang Z
    J Mol Med (Berl); 2016 Sep; 94(9):1063-79. PubMed ID: 27052830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE ROLE OF T REGULATORY AND TH17 CELLS IN THE PATHOGENESIS OF RHEUMATOID ARTHRITIS (REVIEW).
    Kikodze N; Pantsulaia I; Chikovani T
    Georgian Med News; 2016 Dec; (261):62-68. PubMed ID: 28132045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
    Toussirot E
    Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
    Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
    Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 receptor antagonist (IL-1Ra)-Fc ameliorate autoimmune arthritis by regulation of the Th17 cells/Treg balance and arthrogenic cytokine activation.
    Lee SY; Min HK; Lee SH; Shin HJ; Lee WY; Cho YG; Kwok SK; Ju JH; Cho ML; Park SH
    Immunol Lett; 2016 Apr; 172():56-66. PubMed ID: 26903194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients.
    Heo YJ; Joo YB; Oh HJ; Park MK; Heo YM; Cho ML; Kwok SK; Ju JH; Park KS; Cho SG; Park SH; Kim HY; Min JK
    Immunol Lett; 2010 Jan; 127(2):150-6. PubMed ID: 19895848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases.
    Noack M; Miossec P
    Autoimmun Rev; 2014 Jun; 13(6):668-77. PubMed ID: 24418308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive Cell Therapy of Induced Regulatory T Cells Expanded by Tolerogenic Dendritic Cells on Murine Autoimmune Arthritis.
    Yang J; Liu L; Yang Y; Kong N; Jiang X; Sun J; Xie R
    J Immunol Res; 2017; 2017():7573154. PubMed ID: 28702462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.